US Stock MarketDetailed Quotes

VRNA Verona Pharma

Watchlist

26.880
-0.170-0.63%

Close Aug 23 16:00 ET

26.921
+0.041+0.15%

Post 20:02 ET

2.18BMarket Cap-16800P/E (TTM)

Verona Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

19.75%-17.1M

-135.39%-13.61M

16.10%-50.22M

-34.43%-10.4M

29.67%-12.73M

-9.19%-21.31M

60.16%-5.78M

-80.01%-59.86M

55.33%-7.74M

-179.28%-18.1M

Net income from continuing operations

-704.30%-70.84M

-54.06%-25.79M

20.86%-54.37M

-35.22%-14.13M

6.14%-14.69M

50.43%-8.81M

32.59%-16.74M

-23.63%-68.7M

55.07%-10.45M

-241.59%-15.65M

Operating gains losses

590.27%3.63M

123.50%219K

-140.28%-1.87M

51.23%-1.21M

-73.71%1.01M

-134.63%-740K

-183.29%-932K

126.59%4.63M

84.28%-2.47M

448.29%3.85M

Depreciation and amortization

71.97%270K

67.52%263K

6.45%677K

37.75%208K

-1.27%155K

-4.85%157K

-3.68%157K

1.11%636K

-6.79%151K

-3.09%157K

Other non cash items

385.42%233K

89.01%172K

18.09%222K

29.63%35K

-11.11%48K

-9.43%48K

68.52%91K

-21.34%188K

-49.06%27K

0.00%54K

Change In working capital

299.54%34.01M

-1.13%7.27M

-29.43%-13.9M

-75.40%124K

53.52%-4.33M

-138.06%-17.04M

40.34%7.36M

-179.87%-10.74M

-97.08%504K

-257.55%-9.32M

-Change in receivables

302.79%7.79M

74.71%-585K

-127.85%-1.1M

-107.91%-1.03M

111.69%310K

139.59%1.93M

-46.58%-2.31M

157.25%3.96M

21.61%13.08M

-109.41%-2.65M

-Change in prepaid assets

-371.51%-1.81M

-100.53%-5K

-172.69%-1.12M

-133.29%-285K

-277.18%-2.44M

119.14%667K

-66.39%938K

206.99%1.54M

-67.51%856K

-56.25%1.38M

-Change in payables and accrued expense

145.87%7.37M

-19.57%6.77M

29.73%-10.9M

89.49%-1.51M

74.98%-1.76M

-1,557.35%-16.06M

78.03%8.42M

-172.49%-15.51M

-359.40%-14.33M

-172.33%-7.01M

-Change in other current assets

73.15%-907K

-30.84%942K

158.64%777K

7,492.50%3.04M

80.03%-244K

-1,158.93%-3.38M

394.81%1.36M

-69.22%-1.33M

103.95%40K

-121.62%-1.22M

-Change in other current liabilities

10,623.41%21.57M

114.18%149K

-358.93%-1.55M

-110.20%-88K

-210.70%-207K

3.30%-205K

-339.75%-1.05M

179.65%599K

237.20%863K

126.79%187K

Cash from discontinued investing activities

Operating cash flow

19.75%-17.1M

-135.39%-13.61M

16.10%-50.22M

-34.43%-10.4M

29.67%-12.73M

-9.19%-21.31M

60.16%-5.78M

-80.01%-59.86M

55.33%-7.74M

-179.28%-18.1M

Investing cash flow

Cash flow from continuing investing activities

-29K

-16K

-141.67%-29K

Net PPE purchase and sale

---29K

---16K

--0

-141.67%-29K

--0

Cash from discontinued investing activities

Investing cash flow

---29K

---16K

--0

-141.67%-29K

--0

Financing cash flow

Cash flow from continuing financing activities

134,441.94%166.83M

-104.55%-3.12M

-34.05%92.87M

818.59%24.01M

-99.97%48K

118.00%124K

9,560.74%68.69M

2,402.08%140.82M

390.12%2.61M

7,784.04%139.62M

Net issuance payments of debt

--70.24M

--0

674.16%38.71M

474.24%28.71M

--0

--10M

--5M

--0

Net common stock issuance

--0

-62.01%56.91M

--0

--47K

84,768.66%56.86M

20,336.15%149.8M

--0

42,680.00%149.73M

Proceeds from stock option exercised by employees

--0

-55.34%816K

42.06%1.95M

-100.30%-3K

-87.06%48K

--77K

--1.83M

--1.37M

--1M

--371K

Net other financing activities

--96.59M

---3.94M

69.40%-4.7M

----

-124.10%-15.35M

-275.92%-3.39M

-383.71%-10.48M

Cash from discontinued financing activities

Financing cash flow

134,441.94%166.83M

-104.55%-3.12M

-34.05%92.87M

818.59%24.01M

-99.97%48K

118.00%124K

9,560.74%68.69M

2,402.08%140.82M

390.12%2.61M

7,784.04%139.62M

Net cash flow

Beginning cash position

-12.54%254.88M

19.29%271.77M

53.54%227.83M

11.08%257.37M

142.78%270.73M

119.50%291.42M

53.54%227.83M

-21.07%148.38M

39.12%231.7M

-23.64%111.51M

Current changes in cash

806.57%149.7M

-126.63%-16.75M

-47.30%42.65M

365.61%13.61M

-110.43%-12.68M

-4.70%-21.19M

512.80%62.9M

305.49%80.93M

71.88%-5.12M

478.77%121.52M

Effect of exchange rate changes

-96.79%16K

-120.58%-141K

187.70%1.3M

-36.32%796K

48.84%-682K

148.97%499K

281.22%685K

-563.68%-1.48M

2,055.17%1.25M

-174.85%-1.33M

End cash Position

49.45%404.6M

-12.54%254.88M

19.29%271.77M

11.08%257.37M

142.78%270.73M

119.50%291.42M

53.54%227.83M

39.12%231.7M

Free cash flow

19.61%-17.13M

-135.66%-13.63M

16.14%-50.22M

-34.43%-10.4M

29.67%-12.73M

-9.03%-21.31M

60.16%-5.78M

-80.04%-59.89M

55.33%-7.74M

-179.32%-18.1M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	19.75%-17.1M	-135.39%-13.61M	16.10%-50.22M	-34.43%-10.4M	29.67%-12.73M	-9.19%-21.31M	60.16%-5.78M	-80.01%-59.86M	55.33%-7.74M	-179.28%-18.1M
Net income from continuing operations	-704.30%-70.84M	-54.06%-25.79M	20.86%-54.37M	-35.22%-14.13M	6.14%-14.69M	50.43%-8.81M	32.59%-16.74M	-23.63%-68.7M	55.07%-10.45M	-241.59%-15.65M
Operating gains losses	590.27%3.63M	123.50%219K	-140.28%-1.87M	51.23%-1.21M	-73.71%1.01M	-134.63%-740K	-183.29%-932K	126.59%4.63M	84.28%-2.47M	448.29%3.85M
Depreciation and amortization	71.97%270K	67.52%263K	6.45%677K	37.75%208K	-1.27%155K	-4.85%157K	-3.68%157K	1.11%636K	-6.79%151K	-3.09%157K
Other non cash items	385.42%233K	89.01%172K	18.09%222K	29.63%35K	-11.11%48K	-9.43%48K	68.52%91K	-21.34%188K	-49.06%27K	0.00%54K
Change In working capital	299.54%34.01M	-1.13%7.27M	-29.43%-13.9M	-75.40%124K	53.52%-4.33M	-138.06%-17.04M	40.34%7.36M	-179.87%-10.74M	-97.08%504K	-257.55%-9.32M
-Change in receivables	302.79%7.79M	74.71%-585K	-127.85%-1.1M	-107.91%-1.03M	111.69%310K	139.59%1.93M	-46.58%-2.31M	157.25%3.96M	21.61%13.08M	-109.41%-2.65M
-Change in prepaid assets	-371.51%-1.81M	-100.53%-5K	-172.69%-1.12M	-133.29%-285K	-277.18%-2.44M	119.14%667K	-66.39%938K	206.99%1.54M	-67.51%856K	-56.25%1.38M
-Change in payables and accrued expense	145.87%7.37M	-19.57%6.77M	29.73%-10.9M	89.49%-1.51M	74.98%-1.76M	-1,557.35%-16.06M	78.03%8.42M	-172.49%-15.51M	-359.40%-14.33M	-172.33%-7.01M
-Change in other current assets	73.15%-907K	-30.84%942K	158.64%777K	7,492.50%3.04M	80.03%-244K	-1,158.93%-3.38M	394.81%1.36M	-69.22%-1.33M	103.95%40K	-121.62%-1.22M
-Change in other current liabilities	10,623.41%21.57M	114.18%149K	-358.93%-1.55M	-110.20%-88K	-210.70%-207K	3.30%-205K	-339.75%-1.05M	179.65%599K	237.20%863K	126.79%187K
Cash from discontinued investing activities
Operating cash flow	19.75%-17.1M	-135.39%-13.61M	16.10%-50.22M	-34.43%-10.4M	29.67%-12.73M	-9.19%-21.31M	60.16%-5.78M	-80.01%-59.86M	55.33%-7.74M	-179.28%-18.1M
Investing cash flow
Cash flow from continuing investing activities	-29K	-16K	0	0	0	0	0	-141.67%-29K	0	0
Net PPE purchase and sale	---29K	---16K	--0	--0	--0	--0	--0	-141.67%-29K	--0	--0
Cash from discontinued investing activities
Investing cash flow	---29K	---16K	--0	--0	--0	--0	--0	-141.67%-29K	--0	--0
Financing cash flow
Cash flow from continuing financing activities	134,441.94%166.83M	-104.55%-3.12M	-34.05%92.87M	818.59%24.01M	-99.97%48K	118.00%124K	9,560.74%68.69M	2,402.08%140.82M	390.12%2.61M	7,784.04%139.62M
Net issuance payments of debt	--70.24M	--0	674.16%38.71M	474.24%28.71M	--0	--0	--10M	--5M	--5M	--0
Net common stock issuance	--0	--0	-62.01%56.91M	--0	--0	--47K	84,768.66%56.86M	20,336.15%149.8M	--0	42,680.00%149.73M
Proceeds from stock option exercised by employees	--0	-55.34%816K	42.06%1.95M	-100.30%-3K	-87.06%48K	--77K	--1.83M	--1.37M	--1M	--371K
Net other financing activities	--96.59M	---3.94M	69.40%-4.7M	----	----	----	----	-124.10%-15.35M	-275.92%-3.39M	-383.71%-10.48M
Cash from discontinued financing activities
Financing cash flow	134,441.94%166.83M	-104.55%-3.12M	-34.05%92.87M	818.59%24.01M	-99.97%48K	118.00%124K	9,560.74%68.69M	2,402.08%140.82M	390.12%2.61M	7,784.04%139.62M
Net cash flow
Beginning cash position	-12.54%254.88M	19.29%271.77M	53.54%227.83M	11.08%257.37M	142.78%270.73M	119.50%291.42M	53.54%227.83M	-21.07%148.38M	39.12%231.7M	-23.64%111.51M
Current changes in cash	806.57%149.7M	-126.63%-16.75M	-47.30%42.65M	365.61%13.61M	-110.43%-12.68M	-4.70%-21.19M	512.80%62.9M	305.49%80.93M	71.88%-5.12M	478.77%121.52M
Effect of exchange rate changes	-96.79%16K	-120.58%-141K	187.70%1.3M	-36.32%796K	48.84%-682K	148.97%499K	281.22%685K	-563.68%-1.48M	2,055.17%1.25M	-174.85%-1.33M
End cash Position	49.45%404.6M	-12.54%254.88M	19.29%271.77M	19.29%271.77M	11.08%257.37M	142.78%270.73M	119.50%291.42M	53.54%227.83M	53.54%227.83M	39.12%231.7M
Free cash flow	19.61%-17.13M	-135.66%-13.63M	16.14%-50.22M	-34.43%-10.4M	29.67%-12.73M	-9.03%-21.31M	60.16%-5.78M	-80.04%-59.89M	55.33%-7.74M	-179.32%-18.1M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall